Fibrodysplasia Ossificans Progressiva
Description
Fibrodysplasia ossificans progressiva (FOP) is a severely disabling heritable disorder of connective tissue characterized by congenital malformations of the great toes and progressive heterotopic ossification that forms qualitatively normal bone in characteristic extraskeletal sites.
Clinical Features
Top most frequent phenotypes and symptoms related to Fibrodysplasia Ossificans Progressiva
- Intellectual disability
- Seizures
- Global developmental delay
- Hearing impairment
- Scoliosis
- Neoplasm
- Failure to thrive
- Sensorineural hearing impairment
- Pain
- Low-set ears
And another 56 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Based on the latest data available FIBRODYSPLASIA OSSIFICANS PROGRESSIVA have a estimated prevalence of 0.05 per 100k in Europe.— No data available about the known clinical features onset.
Alternative names
Fibrodysplasia Ossificans Progressiva Is also known as stone man syndrome, fop, myositis ossificans progressiva.
Researches and researchers
Doctors, researchs, and experts related to Fibrodysplasia Ossificans Progressiva extracted from public data.
Fibrodysplasia Ossificans Progressiva Experts map
Current Researchs and researchers
-
Clinical expert - Principal investigator of clinical trial - Investigator of research projectPARIS — Dr Genevieve BAUJAT
-
Institution/s:
— CHU Paris - Hôpital Necker-Enfants Malades
— CHU Paris - Hôpital Necker-Enfants Malades
— CHU Paris - Hôpital Necker-Enfants Malades -
Research area/topic::
A Natural History, Non-Interventional, Two-Part Study in Subjects With Fibrodysplasia Ossificans Progressiva (FOP)-FR
-
Institution/s:
-
Coordinator of expert centre - Investigator of clinical trial - Investigator of research projectGENOVA — Dr Maja DI ROCCO
-
Institution/s:
— Diparimento di Pediatria, IRCCS Istituto G. Gaslini - Ospedale Pediatrico -
Research area/topic::
A Natural History, non-Interventional, two-part study in subjects with fibrodysplasia ossificans progressiva (FOP) - IT
-
Institution/s:
-
Responsible for diagnostic tests - Investigator of research project - Director of laboratory - Director of departmentGENOVA — Pr Roberto RAVAZZOLO
-
Institution/s:
— S.C. di Genetica Molecolare e Citogenetica, IRCCS Istituto G. Gaslini - Ospedale Pediatrico
— U.O. C. Clinica Pediatrica, IRCCS Istituto G. Gaslini - Ospedale Pediatrico
— U.O.C. Clinica Pediatrica, IRCCS Istituto G. Gaslini - Ospedale Pediatrico -
Research area/topic::
New treatment strategies for Fibrodysplasia Ossificans Progressiva
-
Institution/s:
-
Investigator of clinical trial - Investigator of research projectLONDON — Dr Richard KEEN
-
Institution/s:
— University College London Medical School and Royal Free Hospital
— Royal National Orthopaedic Hospital -
Research area/topic::
A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)
-
Institution/s:
-
Investigator of clinical trial - Investigator of research projectSTANMORE — Dr Richard KEEN
-
Institution/s:
— University College London Medical School and Royal Free Hospital
— Royal National Orthopaedic Hospital -
Research area/topic::
A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)
-
Institution/s:
Fibrodysplasia Ossificans Progressiva Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
SKI, TGFB2, TGFBR1, TGFBR2, TNXB, ACTA2, SLC2A10, CBS, ACVR1, ATP6V0A2, FKBP14, SLC39A13, ADAMTS2, COL11A1, COL1A2, COL3A1, COL5A1, COL5A2, ZNF469, CHST14 , (...)
View the complete list with 13 more genes
Specificity
4 %
Genes
100 % |
![]() By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
SLC4A4, SPG7, TBK1, ACO2, BEST1, WFS1, ACVR1, OPTN, ASB10, MFRP, CANT1, SBF2, COL4A1, CISD2, TMEM126A, MTPAP, CYP1B1, C12orf65, SH3PXD2B, FOXC1 , (...)
View the complete list with 14 more genes
Specificity
3 %
Genes
100 % |
![]() By Genetic Diagnostic Laboratory University of Pennsylvania School of Medicine (United States).
ACVR1
Specificity
100 %
Genes
100 % |
![]() By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
ACVR1
Specificity
100 %
Genes
100 % |
![]() By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
ACVR1
Specificity
100 %
Genes
100 % |
![]() By CGC Genetics (Portugal).
ACVR1
Specificity
100 %
Genes
100 % |
![]() By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders (Germany).
ACVR1
Specificity
100 %
Genes
100 % |
![]() By PreventionGenetics PreventionGenetics (United States).
ACVR1
Specificity
100 %
Genes
100 % |
You can get up to 27 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM ORPHANET Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50 BROOKE-SPIEGLER SYNDROME; BRSS DESMOSTEROLOSIS CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2